Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

NeuroPace Inc (NPCE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on NeuroPace Inc
Txns: Sold 7,614 shares @ $9.08, valued at $69.1k
Sold 700 shares @ $9.02, valued at $6.3k
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/22/2023 4 Ridley Irina (Chief Legal Officer/Secretary) has filed a Form 4 on NeuroPace Inc
Txns: Granted 80,000 shares @ $0
02/22/2023 4 Kuhn Rebecca (CFO) has filed a Form 4 on NeuroPace Inc
Txns: Granted 80,000 shares @ $0
02/22/2023 4 Morrell Martha (Chief Medical Officer) has filed a Form 4 on NeuroPace Inc
Txns: Granted 80,000 shares @ $0
02/22/2023 4 Favet Michael (CEO) has filed a Form 4 on NeuroPace Inc
Txns: Granted 225,000 shares @ $0
01/09/2023 4 Geiger Uri (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 120,521 options to buy @ $1.535, valued at $185k
01/09/2023 3 Geiger Uri (Director) has filed a Form 3 on NeuroPace Inc
11/23/2022 4 Accelmed Partners II L.P. (10% Owner) has filed a Form 4 on NeuroPace Inc
Txns: Bought 327,893 shares @ $1.499, valued at $491.5k
Bought 62,398 shares @ $1.499, valued at $93.5k
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2022 4 Morrell Martha (Chief Medical Officer) has filed a Form 4 on NeuroPace Inc
Txns: Exercised 192 options to buy @ $0.026, valued at $5
Exercised 384 options to buy @ $0.026, valued at $10
06/21/2022 4 Andrade Lisa (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 18,253 options to buy @ $6.3, valued at $115k
06/21/2022 4 Fischer Frank M (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 18,253 options to buy @ $6.3, valued at $115k
06/21/2022 4 Garfield Greg Shaw (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 18,253 options to buy @ $6.3, valued at $115k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2022 4 Favet Michael (CEO) has filed a Form 4 on NeuroPace Inc
Txns: Granted 155,080 shares @ $0
Granted 310,160 options to buy @ $8.1, valued at $2.5M
03/07/2022 4 Ridley Irina (General Counsel and Secretary) has filed a Form 4 on NeuroPace Inc
Txns: Granted 56,987 shares @ $0
Granted 83,530 options to buy @ $8.15, valued at $680.8k
03/07/2022 4 Kuhn Rebecca (CFO) has filed a Form 4 on NeuroPace Inc
Txns: Granted 46,740 shares @ $0
Granted 93,480 options to buy @ $8.15, valued at $761.9k
03/07/2022 4 Morrell Martha (Chief Medical Officer) has filed a Form 4 on NeuroPace Inc
Txns: Granted 46,760 shares @ $0
Granted 93,530 options to buy @ $8.15, valued at $762.3k
03/01/2022 4 Ridley Irina (General Counsel and Secretary) has filed a Form 4 on NeuroPace Inc
Txns: Sold 1,470 shares @ $7.5386, valued at $11.1k
11/02/2021 4 Andrade Lisa (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 11,836 options to buy @ $15.63, valued at $185k
11/02/2021 3 Andrade Lisa (Director) has filed a Form 3 on NeuroPace Inc
10/08/2021 4 Ryan Renee (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 21,698 options to buy @ $17, valued at $368.9k
10/08/2021 4 Norton Evan (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 21,698 options to buy @ $17, valued at $368.9k
10/08/2021 4 Kumar Rakhi (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 21,698 options to buy @ $17, valued at $368.9k
10/08/2021 4 LACOB JOSEPH (Director) has filed a Form 4 on NeuroPace Inc
Txns: Granted 21,698 options to buy @ $17, valued at $368.9k
06/29/2021 4/A Favet Michael (CEO) has filed a Form 4 on NeuroPace Inc
Txns: Granted 27,000 shares @ $0
Granted 54,000 options to buy @ $21.67, valued at $1.2M
06/29/2021 4/A Morrell Martha (Chief Medical officer) has filed a Form 4 on NeuroPace Inc
Txns: Granted 8,310 shares @ $0
Granted 16,620 options to buy @ $21.67, valued at $360.2k
06/29/2021 4/A Kuhn Rebecca (CFO) has filed a Form 4 on NeuroPace Inc
Txns: Granted 8,310 shares @ $0
Granted 16,620 options to buy @ $21.67, valued at $360.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy